Radiotherapy dose escalation with concurrent chemotherapy in locally advanced cervix cancer is feasible.

Faculty Medicine Year: 2015
Type of Publication: ZU Hosted Pages:
Authors:
Mohamed Wahba Mohamed Mohamed
Journal: Clin Transl Oncol , DOI 10.1007/s12094-015-1336-5 Clin Transl Oncol , DOI 10.1007/s12094-015-1336-5 Volume:
Keywords : Radiotherapy , dose , escalation , with , concurrent , chemotherapy    
Abstract:
Radiotherapy dose escalation with concurrent chemotherapy in locally advanced cervix cancer is feasible.
    
     
 
       

Author Related Publications

  • Mohamed Wahba Mohamed Mohamed, "Cancer Antigen 125 Levels can be Used as a Tumor Marker for Moni-toring Patients with Endometrial Serous Carcinoma?", Int J Cancer Clin Res 2016, 3:075 Vol 3 Issue 8, 2016 More
  • Mohamed Wahba Mohamed Mohamed, "Stereotactic Hypofractionated Accurate Radiotherapy of the Prostate (SHARP), 36.25 Gy in Five Fractions for Localized Prostate Cancer", Gulf Journal of Oncology.Issue 21 May 2016:P12-16, 2016 More
  • Mohamed Wahba Mohamed Mohamed, "Hypofractionated Volumetric Modulated ArcRadiotherapy with simultaneous Elective NodalIrradiation is feasible in prostate cancer patients:A single institution experience", http://dx.doi.org/10.1016/j.jnci.2016.04.001, 2016 More
  • Mohamed Wahba Mohamed Mohamed, "Stereotactic Radiotherapy for Localized Prostate cancer, which is better Cyberknife or Rapid Arc?", Pan Arab Journal of Oncology/Vol. 9/No. 4/December 2016, 2016 More
  • Mohamed Wahba Mohamed Mohamed, "Radiotherapy Dose Escalation with Concurrent Chemotherapy ImprovesOutcome in Locally Advanced Cervix Carcinoma", J Nucl Med Radiat Ther 2016, 7:5DOI: 10.4172/2155-9619.1000304, 2016 More

Department Related Publications

  • Lubna Abdul -Aziz Abdul- Aziz Muhamed, "The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma", Journal of Oncology, 2017 More
  • Heba Mounir AbdelHamid, "Comparison of Prostate-specific Membrane Antigen Reporting and Data System Version 1.0 versus 2.0 for Prostate Cancer Assessment", RSNA, 2025 More
  • Ahmed Ali Eliwa esmail, "Comparison of Prostate-specific Membrane Antigen Reporting and Data System Version 1.0 versus 2.0 for Prostate Cancer Assessment", RSNA, 2025 More
  • Basant Shaaban Mohamed Hafez Desouky, "Comparison of Prostate-specific Membrane Antigen Reporting and Data System Version 1.0 versus 2.0 for Prostate Cancer Assessment", RSNA, 2025 More
  • Ahmed Zien Alabdeen Abdelaziem, "Radiotherapy alone versus concomittent chemoradiation in Early Stage Nasopharyngeal Carcinoma", cancer biology, 2016 More
Tweet